Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 15991 | 8.49 |
09:34 ET | 600 | 8.61 |
09:36 ET | 600 | 8.61 |
09:38 ET | 1900 | 8.69 |
09:39 ET | 2287 | 8.72 |
09:41 ET | 1097 | 8.68 |
09:43 ET | 1883 | 8.66 |
09:45 ET | 700 | 8.67 |
09:48 ET | 2826 | 8.64 |
09:50 ET | 800 | 8.63 |
09:52 ET | 2364 | 8.6 |
09:54 ET | 4807 | 8.53 |
09:56 ET | 3937 | 8.51 |
09:57 ET | 1492 | 8.53 |
09:59 ET | 825 | 8.53 |
10:01 ET | 3860 | 8.4905 |
10:03 ET | 6321 | 8.49 |
10:06 ET | 1014 | 8.505 |
10:08 ET | 2400 | 8.49 |
10:10 ET | 9254 | 8.485 |
10:12 ET | 1623 | 8.485 |
10:14 ET | 2068 | 8.47 |
10:15 ET | 2974 | 8.505 |
10:17 ET | 1737 | 8.545 |
10:19 ET | 2311 | 8.58 |
10:21 ET | 1888 | 8.59 |
10:24 ET | 900 | 8.58 |
10:26 ET | 4166 | 8.565 |
10:28 ET | 18931 | 8.555 |
10:30 ET | 79646 | 8.54 |
10:32 ET | 9608 | 8.61 |
10:33 ET | 11047 | 8.64 |
10:35 ET | 675 | 8.64 |
10:37 ET | 6772 | 8.58 |
10:39 ET | 200 | 8.57 |
10:42 ET | 300 | 8.555 |
10:44 ET | 1265 | 8.56 |
10:46 ET | 1083 | 8.59 |
10:48 ET | 320 | 8.57 |
10:50 ET | 803 | 8.57 |
10:51 ET | 378 | 8.585 |
10:53 ET | 100 | 8.565 |
10:55 ET | 202 | 8.58 |
10:57 ET | 2680 | 8.625 |
11:00 ET | 100 | 8.62 |
11:02 ET | 380 | 8.615 |
11:04 ET | 1251 | 8.645 |
11:06 ET | 3242 | 8.635 |
11:08 ET | 770 | 8.64 |
11:09 ET | 2207 | 8.62 |
11:11 ET | 100 | 8.61 |
11:13 ET | 1998 | 8.61 |
11:15 ET | 300 | 8.595 |
11:18 ET | 2293 | 8.625 |
11:20 ET | 5333 | 8.64 |
11:22 ET | 661 | 8.64 |
11:24 ET | 25743 | 8.66 |
11:26 ET | 12370 | 8.68 |
11:27 ET | 215 | 8.6887 |
11:29 ET | 21938 | 8.68 |
11:33 ET | 39127 | 8.68 |
11:36 ET | 17710 | 8.71 |
11:38 ET | 940 | 8.725 |
11:40 ET | 1419 | 8.74 |
11:42 ET | 300 | 8.745 |
11:44 ET | 1874 | 8.7642 |
11:45 ET | 2200 | 8.725 |
11:47 ET | 900 | 8.72 |
11:49 ET | 1642 | 8.71 |
11:51 ET | 300 | 8.7 |
11:54 ET | 600 | 8.69 |
11:58 ET | 300 | 8.69 |
12:00 ET | 200 | 8.69 |
12:02 ET | 12221 | 8.69 |
12:05 ET | 100 | 8.695 |
12:07 ET | 1938 | 8.705 |
12:12 ET | 1337 | 8.72 |
12:16 ET | 205 | 8.71 |
12:18 ET | 502 | 8.715 |
12:20 ET | 2517 | 8.73 |
12:21 ET | 300 | 8.72 |
12:23 ET | 667 | 8.7 |
12:25 ET | 3331 | 8.69 |
12:27 ET | 200 | 8.68 |
12:30 ET | 3208 | 8.7 |
12:34 ET | 1425 | 8.6899 |
12:36 ET | 1919 | 8.7 |
12:38 ET | 1013 | 8.695 |
12:41 ET | 100 | 8.68 |
12:43 ET | 29420 | 8.67 |
12:45 ET | 10333 | 8.66 |
12:50 ET | 885 | 8.675 |
12:52 ET | 500 | 8.675 |
12:54 ET | 226 | 8.675 |
12:57 ET | 300 | 8.675 |
12:59 ET | 2320 | 8.67 |
01:01 ET | 1364 | 8.67 |
01:03 ET | 100 | 8.675 |
01:06 ET | 2367 | 8.67 |
01:10 ET | 318 | 8.675 |
01:12 ET | 5937 | 8.665 |
01:14 ET | 100 | 8.67 |
01:15 ET | 3635 | 8.61 |
01:17 ET | 6970 | 8.66 |
01:19 ET | 3271 | 8.67 |
01:24 ET | 970 | 8.67 |
01:26 ET | 1584 | 8.67 |
01:28 ET | 100 | 8.6689 |
01:32 ET | 131 | 8.67 |
01:33 ET | 300 | 8.665 |
01:35 ET | 100 | 8.665 |
01:37 ET | 2452 | 8.675 |
01:39 ET | 1174 | 8.67 |
01:42 ET | 4307 | 8.63 |
01:44 ET | 965 | 8.62 |
01:46 ET | 700 | 8.605 |
01:48 ET | 2478 | 8.62 |
01:50 ET | 870 | 8.61 |
01:51 ET | 4361 | 8.64 |
01:53 ET | 200 | 8.65 |
01:55 ET | 100 | 8.655 |
01:57 ET | 100 | 8.66 |
02:00 ET | 600 | 8.66 |
02:02 ET | 893 | 8.65 |
02:04 ET | 975 | 8.655 |
02:06 ET | 600 | 8.68 |
02:08 ET | 1089 | 8.69 |
02:09 ET | 758 | 8.685 |
02:11 ET | 400 | 8.675 |
02:13 ET | 200 | 8.68 |
02:15 ET | 3627 | 8.68 |
02:18 ET | 1168 | 8.69 |
02:22 ET | 3347 | 8.695 |
02:24 ET | 8694 | 8.7 |
02:26 ET | 1116 | 8.71 |
02:27 ET | 1391 | 8.725 |
02:29 ET | 1471 | 8.74 |
02:31 ET | 3560 | 8.715 |
02:33 ET | 2868 | 8.745 |
02:36 ET | 25667 | 8.72 |
02:38 ET | 952 | 8.73 |
02:40 ET | 12914 | 8.77 |
02:42 ET | 1196 | 8.79 |
02:44 ET | 2388 | 8.8 |
02:45 ET | 4474 | 8.82 |
02:47 ET | 840 | 8.84 |
02:49 ET | 5785 | 8.83 |
02:51 ET | 400 | 8.85 |
02:54 ET | 943 | 8.85 |
02:56 ET | 659 | 8.86 |
02:58 ET | 6066 | 8.905 |
03:00 ET | 8807 | 8.94 |
03:02 ET | 4249 | 8.99 |
03:03 ET | 1489 | 8.94 |
03:05 ET | 10075 | 8.89 |
03:07 ET | 3626 | 8.91 |
03:09 ET | 3598 | 8.94 |
03:12 ET | 1979 | 8.94 |
03:14 ET | 2681 | 8.945 |
03:16 ET | 2662 | 8.92 |
03:18 ET | 4727 | 8.88 |
03:20 ET | 4041 | 8.89 |
03:21 ET | 13416 | 8.83 |
03:23 ET | 6217 | 8.85 |
03:25 ET | 4400 | 8.88 |
03:27 ET | 3455 | 8.89 |
03:30 ET | 5504 | 8.86 |
03:32 ET | 7247 | 8.84 |
03:34 ET | 4944 | 8.845 |
03:36 ET | 5670 | 8.84 |
03:38 ET | 3307 | 8.825 |
03:39 ET | 5565 | 8.78 |
03:41 ET | 4642 | 8.76 |
03:43 ET | 4475 | 8.745 |
03:45 ET | 8508 | 8.745 |
03:48 ET | 3876 | 8.755 |
03:50 ET | 6190 | 8.745 |
03:52 ET | 16846 | 8.695 |
03:54 ET | 9675 | 8.69 |
03:56 ET | 23488 | 8.71 |
03:57 ET | 30636 | 8.68 |
03:59 ET | 162541 | 8.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -1.9x | --- |
Prothena Corporation PLC | 1.2B | -7.7x | --- |
Immatics NV | 1.1B | -8.4x | --- |
Arcutis Biotherapeutics Inc | 1.0B | -2.3x | --- |
Abcellera Biologics Inc | 1.1B | -7.5x | --- |
MacroGenics Inc | 972.8M | -102.0x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $86.2M |
Shares Outstanding | 135.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-4.59 |
Book Value | $11.80 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -794.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.